APA

Hashemi Sadraei N., Feng Y., Du L., Fu P., Haque S., Dowlati A., Gollamudi J., Pennell N. A., Mekhail T., Avril S., Farver C., Gerson S. L. & Sharma N. (20190930). High UDG and BRCA1 expression is associated with adverse outcome in patients with pemetrexed treated non-small cell lung Cancer. : Lung cancer (Amsterdam, Netherlands).

Chicago

Hashemi Sadraei Nooshin, Feng Yan, Du Lingling, Fu Pingfu, Haque Sulsal, Dowlati Afshin, Gollamudi Jahnavi, Pennell Nathan A, Mekhail Tarek, Avril Stefanie, Farver Carol, Gerson Stanton L and Sharma Neelesh. 20190930. High UDG and BRCA1 expression is associated with adverse outcome in patients with pemetrexed treated non-small cell lung Cancer. : Lung cancer (Amsterdam, Netherlands).

Harvard

Hashemi Sadraei N., Feng Y., Du L., Fu P., Haque S., Dowlati A., Gollamudi J., Pennell N. A., Mekhail T., Avril S., Farver C., Gerson S. L. and Sharma N. (20190930). High UDG and BRCA1 expression is associated with adverse outcome in patients with pemetrexed treated non-small cell lung Cancer. : Lung cancer (Amsterdam, Netherlands).

MLA

Hashemi Sadraei Nooshin, Feng Yan, Du Lingling, Fu Pingfu, Haque Sulsal, Dowlati Afshin, Gollamudi Jahnavi, Pennell Nathan A, Mekhail Tarek, Avril Stefanie, Farver Carol, Gerson Stanton L and Sharma Neelesh. High UDG and BRCA1 expression is associated with adverse outcome in patients with pemetrexed treated non-small cell lung Cancer. : Lung cancer (Amsterdam, Netherlands). 20190930.